Two leading Silicon Valley venture capital funds were incubating a seed stage telemedicine company that proposed to leverage nurse practitioners. Health Business Group assisted in understanding the market landscape and segmenting prospective customers.
Health care services
Health Business Group supported the development of a strategic plan for a biomedical research institute within a large clinical organization.
Health Business Group evaluated the business case for diversification into freestanding hyperbaric oxygen therapy centers.
A major retail pharmacy chain asked Health Business Group to undertake a review of its medication information offerings.
Health Business Group evaluated the market for cost containment technology and services, and performed due diligence on an acquisition candidate.
A leading hospitalist company was seeking additional growth and evaluating long-term strategic alternatives to maintain a differentiated offering in the marketplace.
Health Business Group nurtured a medical risk management company from its first angel round through a Series B investment. David Williams served as chairman of the board.